
Popular


Ocuphire Granted Two New U.S. Patents Covering Late-Stage Drug Candidate Nyxol®, Including for the Treatment of Presbyopia
Newly Issued Claims Extend Patent Protection to Year 2039 for Nyxol®Combination Therapy for Presbyopia […]

Entheon Biomedical Corp. Provides Corporate Update
Launch of Psychedelics DNA Test Kit,
Phase 1 clinical trial for DMT progressing as planned,
Pre-clinical In Vivo work scheduled to start at Israeli CRO […]

Ocuphire Announces Financial Results for the First Quarter 2021 and Provides Corporate Update
Reported Positive Data in First Pivotal Phase 3 Trial for Nyxol Eye Drops with Plans to Advance Towards NDA Submission and Commercialization in Reversal of Mydriasis Indication […]

XORTX Files New Provisional Patent to Treat and Protect Individuals Most at Risk to Severe Viral Infection
● Compositions and Methods for Enhancing Anti-viral Therapies ●
[…]

Entheon Biomedical Corp. (CSE: ENBI)
Interview with Timothy Ko, CEO […]

ArcPacific Resources Announces AGSM Results
Following the Meeting, Mr. Adrian Smith, Mr. Collin Kim, Mr. Ken Chung, Mr. Kosta Tsoutsis and Mr. Mike Collins will serve on the board of directors. […]

CANAQUEST SIGNS MENTANINE® AND MENTABINOL® PRODUCTION AND DISTRIBUTION AGREEMENT WITH PURCANN PHARMA AND SILICYCLE INC.
PurCann, a subsidiary of SiliCycle, is recognized for its unique expertise in the Extraction-Purification and commercialization of cannabinoids. […]

Recent Milestone Achievements of Sigyn Therapeutics Discussed During CEO Interview
During the interview, Mr. Joyce discusses recent data-driven milestones that reinforce the potential for Sigyn Therapy™ to overcome the limitations of previous strategies to treat sepsis and other life-threatening inflammatory conditions. […]

Eastern Platinum Limited Is Pleased to Report the First Delivery of PGM Circuit D Pressed Filter Cake Concentrate and Provide a Company Update
The Company has generated approximately 134 tons of pressed filter cake PGM concentrate and delivered approximately 32.18 tons during 2020 […]